Recent Updates
Recently added Catalysts
OSUR Positive Sentiment Score: 70/100

OraSure to Participate in Upcoming Investor Conference

Monday, November 18, 2024 1 min read
Key Takeaway: OraSure Technologies, Inc. announced its participation in the Stephens Annual Investment Conference scheduled for November 20, 2024. The company will host a Q&A session at 1 p.m. ET, which will be accessible via a live webcast. The session will also be archived on the investor relations page of OraSure's website for approximately 90 days. This decision highlights OraSure's dedication to engaging with investors and sharing insights into its business operations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a significant investor conference can enhance visibility.
  • Live Q&A session allows for direct engagement with investors.
  • Demonstrates commitment to transparency and communication with stakeholders.

Full Press Release Details

BETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference:
Stephens Annual Investment Conference on Wednesday, November 20, with a Q&A session scheduled for 1 p.m. ET
A live webcast and replay of the Q&A session will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. The webcast will be archived on OraSure’s website and will be available for approximately 90 days.
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiary, DNA Genotek Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Frequently Asked Questions

When is OraSure's Q&A session scheduled?

OraSure's Q&A session is set for 1 p.m. ET on November 20.

Where can I watch the live webcast of the Q&A?

The live webcast will be available on OraSure's investor relations page.

How long will the Q&A session replay be available?

The replay will be accessible for approximately 90 days.

What does OraSure Technologies specialize in?

OraSure specializes in rapid diagnostic tests and sample management solutions.

Tags: OSUR Viatris Investor Conferences Healthcare OraSure Technologies investor conference Stephens Annual Investment Conference healthcare innovation
Last updated: Nov 18, 2024